Literature DB >> 8411264

NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell.

S J Pleasure1, V M Lee.   

Abstract

We have identified a human cell line with a phenotype resembling committed CNS neuronal precursor cells. NTera 2/cl.D1 (NT2/D1) cells expressed nestin and vimentin, intermediate filament (IF) proteins expressed in neuroepithelial precursor cells, as well as MAP1b, a microtubule-associated protein (MAP) expressed in human neuroepithelium. NT2/D1 cells also expressed the cell adhesion molecules NCAM and N-cadherin which are thought to be important in cell-cell interactions within the neuroepithelium. These NT2/D1 cells also expressed small amounts of NF-L, alpha-internexin, NF-M, and MAP2c, indicating that they are committed to a neuronal fate. Previous studies have shown that, following RA treatment, a proportion of NT2/D1 cells terminally differentiate into neurons and that this occurs via an asymmetric stem cell mode of differentiation. In light of the identification of the neuroepithelial phenotype of NT2/D1 cells we decided to examine more closely the relationship of in vitro neurogenesis in NT2/D1 cells, during RA treatment to that of neurons in vivo. Three days after RA treatment, islands of NT2/D1 cells showed increased expression of neurofilament proteins and increased phosphorylation of NF-M. By 10-14 days, these cells began to resemble neurons morphologically, i.e., with rounded cell bodies and processes. These neuronal cells were clustered into clumps which rested on top of a layer of progenitor cells. In this upper layer, the neurons began to express MAP2b and tau and extinguished their expression of nestin. Recently, we developed a method for obtaining pure cultures of neurons from RA treated NT2/D1 cells. The phenotype of these postmitotic neurons is clearly dissociated from that of the untreated NT2/D1 cells. Given the data obtained in this study and the characterization of the neurons derived from NT2/D1 cells, we propose that NT2/D1 cells are a committed human neuronal precursor cell line which retains some stem cell characteristics and is capable only of terminal differentiation into neurons.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8411264     DOI: 10.1002/jnr.490350603

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  97 in total

1.  Characterization and distribution of a new cell surface marker of neuronal precursors.

Authors:  W Schubert; V Coskun; M Tahmina; M S Rao; M B Luskin; Z Kaprielian
Journal:  Dev Neurosci       Date:  2000       Impact factor: 2.984

Review 2.  Ribonucleoprotein infrastructure regulating the flow of genetic information between the genome and the proteome.

Authors:  J D Keene
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

Review 3.  From teratocarcinomas to embryonic stem cells.

Authors:  Peter W Andrews
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

Review 4.  Chemokine receptors and neural function.

Authors:  Charlene Cho; Richard J Miller
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

5.  Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons.

Authors:  S E Merrick; J Q Trojanowski; V M Lee
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

6.  Degenerate suppression PCR identifies the beta2-adrenergic receptor as upregulated by neuronal differentiation.

Authors:  Jan Lewerenz; Frank Leypoldt; Axel Methner
Journal:  Gene Expr       Date:  2003

7.  Gene delivery into neuronal and glial cells by using a replication-deficient adenovirus vector: prospects for neurological gene therapy.

Authors:  S Sivasubramaniam; A Fooks; J Lee; G Stacey; A Jennings
Journal:  Cytotechnology       Date:  1997-09       Impact factor: 2.058

8.  Novel RBPJ transcripts identified in human amniotic fluid cells.

Authors:  Anna Jezierski; Dao Ly; Brandon Smith; Cathie Smith; Roger Tremblay; Andrée Gruslin; Marianna Sikorska; Mahmud Bani-Yaghoub
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

9.  CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons.

Authors:  E Lavi; J M Strizki; A M Ulrich; W Zhang; L Fu; Q Wang; M O'Connor; J A Hoxie; F González-Scarano
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 10.  Cell therapy for stroke.

Authors:  Sean I Savitz; Jonathan H Dinsmore; Lawrence R Wechsler; Daniel M Rosenbaum; Louis R Caplan
Journal:  NeuroRx       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.